Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma

On 10 November, 2018

Retinoblastoma (RB) is a childhood eye cancer. Currently, chemotherapy, local therapy, and enucleation are the main ways in which these tumors are managed. The present work is the first study that uses constraint‐based reconstruction and analysis approaches to identify and explain RB‐specific survival strategies, which are RB tumor specific. Importantly, our model‐specific secretion profile is also found in RB1‐depleted human retinal cells in vitro and suggests that novel biomarkers involved in lipid metabolism may be important. Finally, RB‐specific synthetic lethals have been predicted as lipid and nucleoside transport proteins that can aid in novel drug target development.

Original Paper: 

  • [DOI] S. Sahoo, R. K. Ravi Kumar, B. Nicolay, O. Mohite, K. Sivaraman, V. Khetan, P. Rishi, S. Ganesan, K. Subramanyan, K. Raman, W. Miles, and S. V. Elchuri, “Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma,” FEBS Lett, vol. 593, iss. 1, pp. 23-41, 2019.
    [bibtex]
    @article{sahoo2019metabolite,
      abstract = {Retinoblastoma (RB) is a childhood eye cancer. Currently, chemotherapy, local therapy, and enucleation are the main ways in which these tumors are managed. The present work is the first study that uses constraint-based reconstruction and analysis approaches to identify and explain RB-specific survival strategies, which are RB tumor specific. Importantly, our model-specific secretion profile is also found in RB1-depleted human retinal cells in�vitro and suggests that novel biomarkers involved in lipid metabolism may be important. Finally, RB-specific synthetic lethals have been predicted as lipid and nucleoside transport proteins that can aid in novel drug target development.},
      added-at = {2019-02-10T15:54:29.000+0100},
      author = {Sahoo, S and Ravi Kumar, R K and Nicolay, B and Mohite, O and Sivaraman, K and Khetan, V and Rishi, P and Ganesan, S and Subramanyan, K and Raman, K and Miles, W and Elchuri, S V},
      biburl = {https://www.bibsonomy.org/bibtex/2bfb9bd46463772c47c2ecd07257ff644/karthikraman},
      description = {Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma. - PubMed - NCBI},
      doi = {10.1002/1873-3468.13294},
      interhash = {910f4596de609292b08b2c8135a6756d},
      intrahash = {bfb9bd46463772c47c2ecd07257ff644},
      journal = {FEBS Lett},
      keywords = {myown},
      month = jan,
      number = 1,
      pages = {23-41},
      pmid = {30417337},
      timestamp = {2019-02-10T15:54:29.000+0100},
      title = {Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma},
      url = {https://www.ncbi.nlm.nih.gov/pubmed/30417337},
      volume = 593,
      year = 2019
    }

Comments are closed.